Chronic kidney disease and urologic surgery outcomes

Chronic kidney disease (CKD) is more than an abnormal creatinine result. It is a persistent change in renal structure or function that alters responses to anaesthesia, antibiotics, contrast, fluid shifts and surgery. For patients undergoing urologic procedures, the concern extends beyond whether surgery is possible. The questions are how perioperative kidney injury can be prevented, how complications will be recognised, and which outcomes matter to the individual.

CKD is associated with higher risks of acute kidney injury, dialysis, infection, prolonged hospital stay, readmission and mortality after major surgery. Those risks vary with baseline kidney function, albuminuria, disease cause, urgency and the presence of cardiovascular disease, frailty or malnutrition. A stable, well-characterised condition is different from advanced kidney disease requiring dialysis.

Australian urologists, nephrologists, anaesthetists, nurses and perioperative teams need a shared framework that treats CKD as a dynamic risk factor rather than a binary label. The focus is practical: preoperative characterisation, procedure-specific risk, perioperative management and recovery, with close attention to access, geography and inequity.

Measuring renal risk before decisions

Contemporary CKD assessment combines estimated glomerular filtration rate, albuminuria and persistence. An eGFR below 60 mL/min/1.73 m² for at least three months indicates established CKD, while a higher eGFR may still represent disease when albuminuria is present. Staging must include cause and trajectory. A postoperative rise in creatinine may represent acute kidney injury superimposed on CKD rather than a new diagnosis.

Reduced renal reserve makes kidneys vulnerable to interacting perioperative insults. Hypotension, dehydration, sepsis, obstruction, contrast and nephrotoxic medicines can cause greater injury in people with diabetes or vascular disease. CKD also alters fluid handling and drug clearance. The expected consequence is not a fixed penalty; it is a broader and earlier response to physiological stress.

Risk communication depends on measurable factors rather than labels alone. Baseline eGFR, albuminuria, dialysis status, recent admissions and functional status can inform a documented risk assessment shared with anaesthesia. Peer-reviewed urologic evidence can be located through the journal’s current journal issues, while Australian protocols should guide the final clinical plan.

Building a preoperative assessment

Before elective surgery, clinicians should document serial creatinine and eGFR, urine albumin-to-creatinine ratio, electrolytes, urinalysis and relevant imaging. Trends matter more than a single result. A stable eGFR of 45 differs from a recent decline following infection. Renal imaging should identify hydronephrosis, stones, obstruction or structural abnormalities that could compound operative risk.

A structured medication review should cover ACE inhibitors and ARBs, diuretics, metformin, SGLT2 inhibitors, anticoagulants, antibiotics and non-prescription analgesics. Clinicians should follow current perioperative withholding guidance, use appropriate renal doses and avoid unnecessary NSAIDs. For patients who ask about supplements, a vitamin selection guide can help with checking labels and doses, but the renal team should also review potassium, phosphorus, herbal ingredients and hidden nephrotoxins.

People requiring haemodialysis benefit from a written plan covering vascular access, fluid status, anticoagulation and postoperative dialysis timing. Prehabilitation may address nutrition, smoking, exercise and urinary infection or obstruction before elective surgery. Coordination among urology, nephrology, anaesthesia, pharmacy and nursing is particularly valuable when eGFR is below 30, albuminuria is severe or acute kidney injury has occurred recently.

Matching risk to the procedure

Stone surgery carries several renal risks: injury caused by obstruction, the burden of infection and additional physiological stress. Percutaneous nephrolithotomy and ureteroscopy in advanced CKD should be planned around sepsis prevention, hydration and a clear strategy for managing obstruction. Failed clearance, residual stone burden or delayed drainage can turn an elective operation into a source of acute kidney injury.

Lower-tract surgery also affects systemic and functional outcomes. Transurethral resection of the prostate may provoke fluid absorption and dilutional hyponatraemia, while prostatectomy can increase urinary infection, incontinence and renal stress. Catheter management and continuous bladder irrigation should be balanced against haemodynamics, mobility and infection risk. Baseline lower urinary tract symptoms and a bladder management plan deserve more attention than procedural speed alone.

Nephrectomy requires precise assessment of the remaining kidney, especially when it is the sole functioning organ. Cystectomy and urinary diversion add risks of urine leak, obstruction, infection and electrolyte disturbance. A general clinical reading resource can provide background on these mechanisms, but procedure-specific Australian protocols should determine management and escalation pathways.

Anaesthesia and perioperative care

Anaesthesia should be tailored to renal function and cardiovascular reserve rather than eGFR alone. Preload assessment, blood pressure targets and fluid prescriptions must reflect the procedure, chronic disease and haemodialysis status. Avoiding prolonged hypotension may protect renal perfusion, while excessive fluid can worsen oedema, hypertension and cardiopulmonary stress. Controlled physiological stability is the objective.

Antibiotic prophylaxis, antimicrobial treatment and postoperative analgesia require renal dose consideration, while anticoagulation plans must coordinate with haemostasis and neuraxial procedures. Gabapentinoids and other renally cleared medicines may accumulate in advanced CKD and contribute to sedation, delirium or falls. Medication reconciliation should continue through discharge, because a decision made in theatre does not prevent omissions at home.

Teams should document dialysis timing, renal dosing decisions, infection status and planned fluid goals on the day of surgery. Intraoperative haemodynamics, urine output when relevant, creatinine and electrolytes can guide postoperative care. Avoid unnecessary catheters and nephrotoxins, remove catheters promptly, mobilise patients early and seek renal review when creatinine rises or urine output falls.

Recovery, function and safety

Postoperative surveillance should match baseline kidney function and surgical complexity. Clinicians need to identify acute kidney injury early, distinguish it from expected postoperative changes and respond to worsening electrolytes, fluid balance or oliguria. Patients discharged after major urologic surgery often need repeat renal testing, clear medicine instructions and access to advice when deterioration occurs.

Recovery also includes mobility, continence, nutrition and medication effects. CKD can coexist with frailty, orthostatic symptoms, nocturia and cognitive impairment, while alpha-blockers or antihypertensives may increase dizziness and falls. The site’s incontinence and falls review reinforces that urinary symptoms are safety issues rather than merely cosmetic or administrative concerns.

Functional recovery may lag behind wound healing after prolonged catheter use, complex stone surgery or pelvic cancer treatment. Discharge planning should combine urologic follow-up, renal review, continence support and physiotherapy where needed. For older Australians living independently, avoiding readmission and preserving the ability to manage medicines may matter more than a small difference in a laboratory result.

Australian systems and equity

Australia’s mixed public and private hospital system shapes access to perioperative support. Medicare and the Medicare Benefits Schedule cover many urologic services, while private hospital insurance affects the timing and setting of elective treatment. Public waiting lists can delay correction of obstruction, infection or stones, allowing kidney function to deteriorate. Publicly funded medicines through the Pharmaceutical Benefits Scheme support blood pressure, diabetes and kidney care, although affordability and adherence still vary.

CKD has a heavier burden among Aboriginal and Torres Strait Islander people, with disease often appearing earlier and progressing more quickly. In Melbourne and Sydney, specialist access is greater, yet transport, language barriers and discrimination can still delay treatment. Regional and remote services should work with Aboriginal Community Controlled Health Services, local liaison roles and culturally safe communication rather than relying on a single pathway designed for metropolitan hospitals.

Distance adds another layer across the Northern Territory, Western Australia and northern Queensland. Patients may need aeromedical retrieval, temporary accommodation or relocation for dialysis and surgery; the Royal Flying Doctor Service and local retrieval networks demonstrate the scale of these barriers. Tertiary urology units in Melbourne, Sydney, Brisbane and Perth provide complex care, while regional renal teams coordinate dialysis, transport and follow-up. Local protocols should specify responsibility whenever complications cross hospital boundaries.

Translating evidence into action

Informed consent should describe CKD-related risk in personal terms, including acute kidney injury, dialysis, infection, impaired wound healing and possible changes in continence or function. Conservative treatment, staged procedures and alternatives should be discussed when they offer comparable cancer control or symptom relief. Patients need a clear postoperative plan with warning signs, medication instructions and a named clinical contact.

Research gaps remain because CKD is often grouped into broad categories, while albuminuria, frailty, dialysis and surgical complexity are reported inconsistently. Australian cohorts need to represent remote communities, Aboriginal and Torres Strait Islander patients and people with multiple chronic conditions. Evidence synthesis should report acute kidney injury, dialysis and longer-term renal function directly.

Teams can act by adding a structured CKD assessment to every urologic surgical pathway, linking it to eGFR, albuminuria, medication review, anaesthetic planning and dialysis escalation. Patients can prepare by bringing medicines and recent test results and leaving with written advice on fluids, wound care and warning symptoms. Institutions can support this work through audit, renal review and staff education, using the Urological Science journal to identify relevant evidence and adapt it to Australian guidance and local resources.